Boğaziçi University Center for Targeted Therapy Technologies (Boğaziçi CT³) supports the establishment and long-term sustainability of scientific and technological collaborations between start-ups and university-based researchers, academics, and clinicians. Through joint project development, access to research infrastructure, shared use of instruments and laboratories, training activities, and tailored technical consultancy, the Center aims to strengthen ventures’ R&D capabilities and innovation speed.

In this framework, Boğaziçi CT³ helps bring the right stakeholders together across the full pathway—from early-stage concepts to validation and prototyping—enhancing interdisciplinary interaction and encouraging solutions aligned with real clinical needs. As a result, ventures increase their potential for translating scientific outcomes into market-ready innovations, while the university ecosystem benefits from impact-driven and sustainable partnerships.